Heptares announced in a press release today that the first subject has been dosed in this ‘phase 1 clinical study of novel selective muscarinic M4 agonist in...
Read moreLatest Articles
Latest Articles
Applications are open for the Clinical Research Training Fellowship programme with the MRC
The Medical Research Council (MRC) Medicines Development Fellowship Scheme is...
HMR’s Environmental Management System receives ISO 14001 certification
On 21 May 2024, HMR’s Environmental Management System received ISO 14001...
HMR will take part in the MRC Medicines Development Fellowship Programme
HMR is pleased to announce that it will take part in the Medical Research...
HMR offers Biomedical Scientist Apprenticeships
HMR offers Biomedical Scientist apprenticeships with a BSc (Hons) in Applied...